Thousand Oaks Biopharmaceuticals
PrivateLast Round
Series C
Mar 10, 2021
Total Funding Raised
$170.4M
Company Overview
Thousand Oaks Biopharmaceuticals is a biotechnology company that offers contract development and manufacturing company (CDMO) services, enabling partners to provide accessible and affordable biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Clinical Trials, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thousand Oaks Biopharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Thousand Oaks Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 10, 2021 | ||||
| Series B | Jul 24, 2020 | ||||
| Series A | Jan 3, 2019 |
Thousand Oaks Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series C |
| New Alliance Capital | Series A |
| CDH Investments | Series C |
| 中信金石投资有限公司 | Series C |
| GL Ventures | Series B, Series C |
| CCB International | Series B |
| SANY Group | Series C |
Thousand Oaks Biopharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Thousand Oaks Biopharmaceuticals's valuation, stock price, and market status.
